Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Hoffmann-La Roche
Institut du Cancer de Montpellier - Val d'Aurelle
Jonsson Comprehensive Cancer Center
Tanabe Pharma America, Inc.
Merck Sharp & Dohme LLC
Jonsson Comprehensive Cancer Center
Turning Point Therapeutics, Inc.
Grupo Espanol de Tumores Neuroendocrinos
Hoffmann-La Roche
Instituto do Cancer do Estado de São Paulo
Hutchmed
University Hospital, Basel, Switzerland
Hoffmann-La Roche
Instituto do Cancer do Estado de São Paulo